|
A Dose Escalation Study of GS-7340-02 in Treatment Naive Patients Clinical Trials Facts presented on Clinical Trials Search isn't designed to be a substitute for proven healthcare advice, calls or treatment by using a genuine medical doctor. We aren't mDs. Always confer with your doctor on A Dose Escalation Study of GS-7340-02 in Treatment Naive Patients conditions. Clinical Trials Search.org is a website devoted to listing clinical research studies in human subjects. A Dose Escalation Study of GS-7340-02 in Treatment Naive Patients Clinical research trials and A Dose Escalation Study of GS-7340-02 in Treatment Naive Patients healthcare trials occur in a lot of of places across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the effectivity of new does drugs. The role of the studies / undertakings is to solve specific human healthcare questions. Clinical trials are a popular way for doctors, government agencies, and private sector companies to find treatments for all kinds of conditions, including A Dose Escalation Study of GS-7340-02 in Treatment Naive Patients. A Dose Escalation Study of GS-7340-02 in Treatment Naive Patients Clinical Trials and other clinical trials allow for volunteers to access health treatment choices before they are available to the general public. Many times the test subjects get treatment for without cost, and sometimes they are compensated for their time. Occasionally there is a cost for a A Dose Escalation Study of GS-7340-02 in Treatment Naive Patients clinical trial. Test subjects typically receive the most effective healthcare possible for their A Dose Escalation Study of GS-7340-02 in Treatment Naive Patients condition. Risks are a reality, nonetheless, and could include extra or frequent dr. calls, health hazards (perhaps life-jeopardizing), and/or the treatment being ineffective. Trials are federally regulated with rigid guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "A" Clinical Trials Conditions > A Dose Escalation Study of GS-7340-02 in Treatment Naive Patients  A Dose Escalation Study of GS-7340-02 in Treatment Naive Patients
A Dose Escalation Study of GS-7340-02 in Treatment Naive Patients
For Condition: HIV Infections
Status: Recruiting
Sponsor(s): Gilead Sciences ,
Synopsis: This study will look at two doses of GS-7340-02 versus tenofovir DF.
Details:
Eligibility:
Study Type: Interventional, Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment, Safety/Efficacy Study
Minimum Age/Maximum Age: 18 Years/65 Years
Genders: Both
Protocol Entry Criteria: Inclusion Criteria - HIV-1 RNA levels greater than or equal to 30,000 copies/mL - CD4 count greater than or equal to 200 cells/mm3 - Serum creatinine <1.5 mg/dl - Hepatic transaminases less than or equal to 2.5 times the upper limit of normal - Total bilirubin less than or equal to 1.5 mg/dL - Adequate hematologic function - Serum amylase less than or equal to 1.5 times the upper limit of normal - Serum phosphate greater than or equal to 2.2 mg/dL - Not pregnant Exclusion Criteria - Prior treatment with antiretroviral therapy - Immunization within 30 days of study entry - A new AIDS defining condition within 30 days of study entry - Receiving nephrotoxic agents, probenecid, chemotherapeutic agents, corticosteroids, interleukin-2
Total Enrollment: 30
Location and Contact Information:
Rockefeller University Hospital *Recruiting*
New York City, New York, 10021
United States
Recruiting Arlene Hurley 212-327-7281
Stanford Positive Care Program *Recruiting*
Palo Alto, California, 94304
United States
Recruiting Kim Vu 650-498-5306
Protocare Trials Chicago Center for Clinical Trials *Recruiting*
Chicago, Illinois, 60610
United States
Recruiting Debbie Carpenter 312-494-2317
Additional Information:
Study ID Numbers: GS-120-1101;
Study Start Date: March 2002
Record last reviewed: May 2002
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00036634
Other Hiv Infections Studies:
1. Leukapheresis to Obtain Plasma or Lymphocytes for Studies of HIV-infected Patients, including Long-term Non-progressors
2. A Randomized, Placebo-Controlled Study of the Safety and Efficacy of Efavirenz, Didanosine, and Stavudine in Combination With or Without Hydroxyurea in Antiretroviral Naive or Experienced HIV-Infected Patients
3. (Ro 24-2027) A Randomized, Double-Blind, Comparative Study of Dideoxycytidine (ddC) versus Zidovudine (AZT) in Patients With AIDS or Advanced ARC
4. A Comparison of Lamivudine and Zidovudine, Used Alone and Together, in HIV-Infected Patients Who Have Not Used Zidovudine in the Past
5. Treatment of Acute HIV Infection to Preserve Immune Function
Related Studies:
Other HIV Infections Clinical Trials
Other Illinois Clinical Trials
Other Chicago Clinical Trials
A Dose Escalation Study of GS-7340-02 in Treatment Naive Patients
|
|
|
|
|
|
|
|
